Metastatic carcinoma of unknown primary with complete metabolic response following sorafenib-based chemotherapy
نویسندگان
چکیده
منابع مشابه
Complete Response to Sorafenib Rechallenge in a Patient with Metastatic Renal Cell Carcinoma
A 79-year-old Japanese man underwent a medical examination for hoarseness. Computed tomography revealed a left renal tumor, and radical nephrectomy was performed. The tumor was a clear cell carcinoma. Fourteen months after the operation, the tumor had metastasized to the spleen, right lung, and retroperitoneal lymph nodes. We initiated molecular targeted therapy sequentially with sorafenib, sun...
متن کاملCetuximab Related Eyelash Elongations for Patients with Metastatic Rectum Carcinoma: Metabolic Complete Response
504 Ann Dermatol Received August 29, 2011, Revised November 29, 2012, Accepted for publication December 7, 2012 Corresponding author: Yüksel Ürün, Department of Medical Oncology, Ankara University School of Medicine, Ankara 06590, Turkey. Tel: 90312-595-7112, Fax: 90-312-319-2283, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Att...
متن کاملMetastatic Carcinoma of Unknown Primary Presenting as Jugular Venous Thrombosis
Jugular venous thrombosis is unusual and is associated with central venous catheterisation, intravenous drug abuse and head and neck sepsis. It is rarely associated with malignancy. We report a case of metastatic carcinoma of unknown primary in a forty year old female which presented with jugular venous thrombosis. The discussion includes investigation and treatment options for this condition.
متن کاملMetastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry.
Carcinoma of unknown primary origin (CUP) is one of the 10 most prevalent malignancies. CUP patients in whom a site of origin can be ascribed have better outcomes than those in which the primary tumor remains unidentified. Among the tools available to pathologists in approaching these lesions, immunohistochemistry is a reliable, inexpensive, and widely available resource. New markers continue t...
متن کاملComplete clinical response of metastatic hepatocellular carcinoma to sorafenib in a patient with hemochromatosis: A case report
Hepatocellular carcinoma is rare, but increasing in prevalence in the United States. Recent studies have shown that sorafenib, a multikinase inhibitor, can reduce tumor progression in patients with this cancer. However, complete remission has not been observed. We report a case of a 78-year old patient with unresectable metastatic hepatocellular carcinoma who had a rapid and complete clinical r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: SAGE Open Medical Case Reports
سال: 2019
ISSN: 2050-313X,2050-313X
DOI: 10.1177/2050313x19838739